β-N-Oxalyl-l-α,β-diaminopropionic acid regulates mitogen-activated protein kinase signaling by down-regulation of phosphatidylethanolamine-binding protein 1

Journal of Neurochemistry

Volumn 118, Issue 2, 2011, Pages 176-186

  Jammulamadaka, Nalini ^a   Burgula, Sandeepta ^a   Medisetty, Rajesh ^a   Ilavazhagan, Govindan ^a,b   Rao, S L N ^a   Singh, Surya S ^a  

^a OSMANIA UNIVERSITY   (India)

^b DEFENCE INSTITUTE OF PHYSIOLOGY AND ALLIED SCIENCES   (India)

Author keywords

HIF1 ; hypoxia; l ODAP; neurolathyrism; PEBP; PKC

Indexed keywords

3 OXALYLAMINOALANINE; GLUTAMIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; KAINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN 1; PROTEIN KINASE C; RAF PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHICK; CONTROLLED STUDY; CONVULSION; ENZYME ACTIVATION; ENZYME REGULATION; EXCITOTOXICITY; HUMAN; HUMAN CELL; MALE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SEIZURE; SIGNAL TRANSDUCTION;

AMINO ACIDS, DIAMINO; ANIMALS; CELL LINE, TUMOR; CHICKENS; DOWN-REGULATION; HUMANS; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; RATS;

GALLUS GALLUS;

EID: 79960016323     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07299.x     Document Type: Article

References (53)

1. Akers R. F., Lovinger D. M., Colley P. A., Linden D. J., and, Routtenberg A., (1986) Translocation of protein kinase C activity may mediate hippocampal long-term potentiation. Science 231, 587-589.
2. Banfield M. J., Barker J. J., Perry A. C., and, Brady R. L., (1998) Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure 6, 1245-1254. (Pubitemid 28485957)
3. Beach S., Tang H., Park S., Dhillon A. S., Keller E. T., Kolch W., and, Yeung K. C., (2008) Snail is a repressor of RKIP transcription in metastatic prostate cancer cells. Oncogene 27, 2243-2248. (Pubitemid 351483382)
4. Beal M. F., (1992) Role of excitotoxicity in human neurological disease. Curr. Opin. Neurobiol. 2, 657-662.
5. Beshir A. B., Ren G., Magpusao A. N., Barone L. M., Yeung K. C., and, Fenteany G., (2010) Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Lett. 299, 137-149.
6. Bridges R. J., Kadri M. M., Monaghan D. T., Nunn P. B., Watkins J. C., and, Cotman C. W., (1988) Inhibition of [3H]alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid binding by the excitotoxin beta-N-oxalyl-l-alpha,beta- diaminopropionic acid. Eur. J. Pharmacol. 145, 357-359. (Pubitemid 18018859)
7. Bridges R. J., Stevens D. R., Kahle J. S., Nunn P. B., Kadri M., and, Cotman C. W., (1989) Structure-function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: evidence that beta-l-ODAP is a selective non-NMDA agonist. J. Neurosci. 9, 2073-2079. (Pubitemid 19156994)
8. Burgula S., Medisetty R., Jammulamadaka N., Musturi S., Ilavazhagan G., and, Singh S. S., (2009) Downregulation of PEBP1 in rat brain cortex in hypoxia. J. Mol. Neurosci. 41, 36-47.
9. Butterfield D. A., Perluigi M., and, Sultana R., (2006) Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics. Eur. J. Pharmacol. 545, 39-50. (Pubitemid 44215876)
10. Cardell M., and, Wieloch T., (1993) Time course of the translocation and inhibition of protein kinase C during complete cerebral ischemia in the rat. J. Neurochem. 61, 1308-1314. (Pubitemid 23285088)
11. Cheema P. S., Padmanaban G., and, Sarma P. S., (1970) Biochemical characterization of β-N-oxalyl-l-α,β-diaminopropionic acid the Lathyrus sativus neurotoxin as an excitant amino acid. J. Neurochem. 17, 1295-1298.
12. Chen Q., Wang S., Thompson S. N., Hall E. D., and, Guttmann R. P., (2006) Identification and characterization of PEBP as a calpain substrate. J. Neurochem. 99, 1133-1141. (Pubitemid 44655279)
13. Corbit K. C., Trakul N., Eves E. M., Diaz B., Marshall M., and, Rosner M. R., (2003) Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. J. Biol. Chem. 278, 13061-13068. (Pubitemid 36800074)
14. Fikre A., Van Moorhem M., Ahmed S., Lambein F., and, Gheysen G., (2011) Studies on neurolathyrism in Ethiopia: dietary habits, perception of risks and prevention. Food Chem. Toxicol. 49, 678-684.
15. George A. J., Holsinger R. M., McLean C. A., Tan S. S., Scott H. S., Cardamone T., Cappai R., Masters C. L., and, Li Q. X., (2006) Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Aging 27, 614-623. (Pubitemid 43290530)
16. Goumon Y., Angelone T., Schoentgen F., et al. (2004) The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J. Biol. Chem. 279, 13054-13064. (Pubitemid 38445883)
17. Hengst U., Albrecht H., Hess D., and, Monard D., (2001) The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors. J. Biol. Chem. 276, 535-540. (Pubitemid 32050348)
18. Karin M., (1995) The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270, 16483-16486.
19. Keller E. T., (2004) Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP). Anticancer Drugs 15, 663-669. (Pubitemid 39099915)
20. Klysik J., Theroux S. J., Sedivy J. M., Moffit J. S., and, Boekelheide K., (2008) Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell. Signal. 20, 1-9. (Pubitemid 350138364)
21. La Bella V., Alexianu M. E., Colom L. V., Ionescu A., Mohamed A. H., and, Appel S. H., (1996) Apoptosis induced by beta-N-oxalylamino-l-alanine on a motoneuron hybrid cell line. Neuroscience 70, 1039-1052.
22. Lallena M. J., Diaz-Meco M. T., Bren G., Paya C. V., and, Moscat J., (1999) Activation of IkappaB kinase beta by protein kinase C isoforms. Mol. Cell. Biol. 19, 2180-2188. (Pubitemid 29098275)
23. Liu W. S., and, Heckman C. A., (1998) The sevenfold way of PKC regulation. Cell. Signal. 10, 529-542. (Pubitemid 28438329)
24. Lorenz K., Lohse M. J., and, Quitterer U., (2003) Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574-579. (Pubitemid 37522645)
25. Luo D., Wang J., Li J., and, Post M., (2011) Mouse snail is a target gene for HIF. Mol. Cancer Res. 9, 234-245.
26. Maki M., Matsukawa N., Yuasa H., Otsuka Y., Yamamoto T., Akatsu H., Okamoto T., Ueda R., and, Ojika K., (2002) Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. J. Neuropathol. Exp. Neurol. 61, 176-185. (Pubitemid 34127101)
27. Nelson T. J., and, Alkon D. L., (2009) Neuroprotective versus tumorigenic protein kinase C activators. Trends Biochem. Sci. 34, 136-145.
28. Ojika K., and, Appel S. H., (1984) Neurotrophic effects of hippocampal extracts on medial septal nucleus in vitro. Proc. Natl. Acad. Sci. U S A 81, 2567-2571.
29. Ojika K., Kojima S., Ueki Y., Fukushima N., Hayashi K., and, Yamamoto M., (1992) Purification and structural analysis of hippocampal cholinergic neurostimulating peptide. Brain Res. 572, 164-171.
30. Ojika K., Mitake S., Kamiya T., Kosuge N., and, Taiji M., (1994) Two different molecules, NGF and free-HCNP, stimulate cholinergic activity in septal nuclei in vitro in a different manner. Brain Res. Dev. Brain Res. 79, 1-9. (Pubitemid 24151805)
31. Ojika K., Mitake S., Tohdoh N., Appel S. H., Otsuka Y., Katada E., and, Matsukawa N., (2000) Hippocampal cholinergic neurostimulating peptides (HCNP). Prog. Neurobiol. 60, 37-83. (Pubitemid 30001451)
32. Rao S. L. N, (1978) Entry of β-N-oxalyl-l-α,β- diaminopropionic acid, the Lathyrus sativus neurotoxin into the central nervous system of the adult rat, chick and the rhesus monkey. J. Neurochem. 30, 1467-1470. (Pubitemid 8377492)
33. Rao S. L. N., (2011) A look at the brighter facets of, β-N-oxalyl-l-α,β-diaminopropionic acid, homoarginine and the grass pea. Food Chem. Toxicol. 49, 620-622.
34. Rao S. L. N., Adiga P. R., and, Sarma P. S., (1964) The isolation and characterization of β-N-oxalyl-l-α,β-diaminopropionic acid: a neurotoxin from the seeds of Lathyrus sativus. Biochemistry 3, 432-436.
35. Ravindranath V., (2002) Neurolathyrism: mitochondrial dysfunction in excitotoxicity mediated by l-beta-oxalyl aminoalanine. Neurochem. Int. 40, 505-509. (Pubitemid 34159151)
36. Ross S. M., Roy D. N., and, Spencer P. S., (1989) Beta-N-oxalylamino-l- alanine action on glutamate receptors. J. Neurochem. 53, 710-715.
37. Shasi Vardhan K., Pratap Rudra M. P., and, Rao S. L. N., (1997) Inhibition of tyrosine aminotransferase by β-N-oxalyl-l-α,β- diaminopropionic acid, the Lathyrus sativus neurotoxin. J. Neurochem. 68, 2477-2484. (Pubitemid 27218169)
38. Shrivastava K., Ram M. S., Bansal A., Singh S. S., and, Ilavazhagan G., (2008) Cobalt supplementation promotes hypoxic tolerance and facilitates acclimatization to hypobaric hypoxia in rat brain. High Alt. Med. Biol. 9, 63-75. (Pubitemid 351363938)
39. Singh M. R., Pratap Rudra M. P., Rao S. L. N, and, Singh S. S., (2004) In vitro activation of protein kinase C by β-N-oxalyl-l-α,β- diaminopropionic acid, the Lathyrus sativus neurotoxin. Neurochem. Res. 29, 1343-1348. (Pubitemid 39011318)
40. Spencer P. S., Roy D. N., Ludolph A., Hugon J., Dwivedi M. P., and, Schaumburg H. H., (1986) Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA. Lancet 2, 1066-1067. (Pubitemid 17173955)
41. Sriram K., Shankar S. K., Boyd M. R., and, Ravindranath V., (1998) Thiol oxidation and loss of mitochondrial complex I precede excitatory amino acid-mediated neurodegeneration. J. Neurosci. 18, 10287-10296. (Pubitemid 29016548)
42. Takemura T., Nakamura S., Yokota D., Hirano I., Ono T., Shigeno K., Fujisawa S., and, Ohnishi K., (2010) Reduction of Raf kinase inhibitor protein expression by Bcr-Abl contributes to chronic myelogenous leukemia proliferation. J. Biol. Chem. 285, 6585-6594.
43. Trakul N., and, Rosner M. R., (2005) Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein. Cell Res. 15, 19-23. (Pubitemid 41653959)
44. Tsugu Y., Ojika K., Matsukawa N., Iwase T., Otsuka Y., Katada E., and, Mitake S., (1998) High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. Eur. J. Neurol. 5, 561-569. (Pubitemid 28528810)
45. Vaccarino F., Guidotti A., and, Costa E., (1987) Ganglioside inhibition of glutamate-mediated protein kinase C translocation in primary cultures of cerebellar neurons. Proc. Natl. Acad. Sci. U S A 84, 8707-8711.
46. Vaccarino F. M., Liljequist S., and, Tallman J. F., (1991) Modulation of protein kinase C translocation by excitatory and inhibitory amino acids in primary cultures of neurons. J. Neurochem. 57, 391-396.
47. 2+ handling as an early event in excitotoxicity. Cell Calcium 47, 287-296.
48. Wieloch T., Cardell M., Bingren H., Zivin J., and, Saitoh T., (1991) Changes in the activity of protein kinase C and the differential subcellular redistribution of its isozymes in the rat striatum during and following transient forebrain ischemia. J. Neurochem. 56, 1227-1235. (Pubitemid 21902040)
49. Willis C. L., Meldrum B. S., Nunn P. B., Anderton B. H., and, Leigh P. N., (1994) Neuroprotective effect of free radical scavengers on beta-N-oxalylamino-l-alanine (BOAA)-induced neuronal damage in rat hippocampus. Neurosci. Lett. 182, 159-162. (Pubitemid 24380227)
50. Yeung K., Seitz T., Li S., et al. (1999) Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173-177. (Pubitemid 29436321)
51. Yeung K., Janosch P., McFerran B., Rose D. W., Mischak H., Sedivy J. M., and, Kolch W., (2000) Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the raf kinase inhibitor protein. Mol. Cell. Biol. 20, 3079-3085. (Pubitemid 30215020)
52. Yeung K. C., Rose D. W., Dhillon A. S., Yaros D., Gustafsson M., Chatterjee D., McFerran B., Wyche J., Kolch W., and, Sedivy J. M., (2001) Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol. Cell. Biol. 21, 7207-7217. (Pubitemid 32953475)
53. Zeng L., Imamoto A., and, Rosner M. R., (2008) Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Exp. Opin. Ther. Targets 12, 1275-1287.